Novel small molecule inhibitors to treat brain cancer and neurological diseases Hilde Nilsen, anchored at UiO, Klinmed together with Torkild Visnes, anchored at SINTEF BTN is generating novel inhibitors targeting DNA repair machinery to target Parkinson's disease. Deo Pandey anchored at UiO, Klinmed is generating novel inhibitors targeting transcriptional machinery to treat brain cancers. Johanne Egge Rinholm anchored at UiO, MedFak works on stroke and ischemia and pioneered iPSC-derived brains to evaluate novel approaches to target stroke and ischemia. Both Hilde Nilsen and Deo Pandey have long-term ongoing collaborations with Johanne Egge Rinholm and Torkild Visnes. Novel small molecule inhibitors to treat brain cancer and neurological diseases Hilde Nilsen, anchored at UiO, Klinmed together with Torkild Visnes, anchored at SINTEF BTN is generating novel inhibitors targeting DNA repair machinery to target Parkinson's disease. Deo Pandey anchored at UiO, Klinmed is generating novel inhibitors targeting transcriptional machinery to treat brain cancers. Johanne Egge Rinholm anchored at UiO, MedFak works on stroke and ischemia and pioneered iPSC-derived brains to evaluate novel approaches to target stroke and ischemia. Both Hilde Nilsen and Deo Pandey have long-term ongoing collaborations with Johanne Egge Rinholm and Torkild Visnes. Novel small molecule inhibitors to treat brain cancer and neurological diseases Hilde Nilsen, anchored at UiO, Klinmed together with Torkild Visnes, anchored at SINTEF BTN is generating novel inhibitors targeting DNA repair machinery to target Parkinson's disease. Deo Pandey anchored at UiO, Klinmed is generating novel inhibitors targeting transcriptional machinery to treat brain cancers. Johanne Egge Rinholm anchored at UiO, MedFak works on stroke and ischemia and pioneered iPSC-derived brains to evaluate novel approaches to target stroke and ischemia. Both Hilde Nilsen and Deo Pandey have long-term ongoing collaborations with Johanne Egge Rinholm and Torkild Visnes.